个人简介
廖月玲 女,博士,高级实验师,1984年生于浙江瑞安,2007年于浙江海洋大学获得理学学士学位,生物科学专业,2012年于上海中医药大学获得医学博士学位,中西医结合基础专业,研究方向为中药活性成分对心血管疾病的作用机理研究,2012-2019年就职于上海交通大学医学院/基础医学院病理生理系,细胞分化与凋亡教育部重点实验室,主要从事肺癌发生发展、转移等机理研究。目前,主要从事苦荞麦等生物活性成分防治肿瘤的研究。
以通讯作者或第一作者在Molecules, JCI Insight, Cancer Research, International Journal of Cancer, BBRC等国内外期刊发表研究论文近10篇.
主要研究方向
生物活性成分防治肿瘤的机理研究。
发表论文
1. Mingxing Huo, Aowen Xia, Wenwen Cheng, Mengjie Zhou, Jiankang Wang, Tiantian Shi, Cifeng Cai, Wenqi Jin, Meiliang Zhou, Yueling Liao*, Zhiyong Liao*. Rutin Promotes Pancreatic Cancer Cell Apoptosis by Upregulating miRNA-877-3p Expression. Molecules, 2022, 27(7): 2293. (共同通讯作者)
2. Hongyong Song#, Xiaofeng Ye#, Yueling Liao#, Siwei Zhang, Dongliang Xu, Shuangshuang Zhong, Bo Jing, Tong Wang, Beibei Sun, Jianhua Xu, Wenzheng Guo, Kaimi Li, Min Hu, Yanbin Kuang, Jing Ling, Tuo Zhang, Yadi Wu, Jing Du, Feng Yao, Yugene Chin, Qi Wang, Binhua P. Zhou*, Jiong Deng*. NFκB induces epigenetic repression of GPRC5A in lung epithelial cells to promote neoplasia. JCI Insight. 2023, 8(1):e153976. (共同一作)
3. Hongyong Song#, Beibei Sun#, Yueling Liao#, Dongliang Xu, Wenzheng Guo, Tong Wang, Bo Jing, Min Hu, Kaimi Li, Feng Yao* and Jiong Deng*, GPRC5A deficiency leads to dysregulated MDM2 via activated EGFR signaling for lung tumor development, International Journal of Cancer, 2019, 144(4):777-787.(共同一作)
4. Shuangshuang Zhong#, Huijing Yin#,Yueling Liao#, Feng Yao#, Qi Li, Jie Zhang, Huike Jiao,Yongxu Zhao, Dongliang Xu, Shuli Liu, Hongyong Song,Yong Gao, Jingyi Liu, Lina Ma, Zhi Pang, Ruixu Yang, Chengyi Ding, Beibei Sun, Xiaofeng Lin, Xiaofeng Ye,Wenzheng Guo, Baohui Han, Binhua P. Zhou*, Y. Eugene Chin*, and Jiong Deng*, Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling, Cancer Research, 2015, 75(9):1801-1.(共同一作)
5. Yueling Liao#, Hongyong Song#, Dongliang Xu#, Huike Jiao, Feng Yao, Jingyi Liu, Yadi Wu, Shuangshuang Zhong, Huijing Yin, Shuli Liu, Xiaofei Wang, Wenzheng Guo, Beibei Sun, Baohui Han, Y. Eugene Chin, and Jiong Deng, Gprc5a-deficiency confers susceptibility to endotoxin-induced acute lung injury via NF-kB pathway, Cell Cycle, 2015, 14(9): 1403-1412.(第一作者)
科研课题
(1) 国家自然科学基金委员会,面上项目,32370759,SARS-CoV-2病毒蛋白NSP14通过EGFR信号抑制肺损伤应答与再生的功能机制研究,2024-01-01 至 2027-12-31,50万元,参与
(2) 浙江省科技厅,浙江省重点研发计划项目,2022C04003,荞麦饲料对家畜肉品质形成的调控机制及产业化示范推广,2022-01 至 2024-12,50万元,参与
联系电话 15858556130
电子邮箱 20190207@wzu.edu.cn, lylsolo@126.com